Advertisement

Topics

Sarepta Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock

05:30 EDT 23 Sep 2016 | Biotech-Finances

Thursday, September 22nd 2016 at 10:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-targeted therapeutics, today announced that it has priced an underwritten public offering of an aggregate of 5.02 million shares of its common stock at a price to the public of $59.75 per share. In addition, Sarepta …

Cet article Sarepta Therapeutics Announces Pricing of $300 Million Public
Offering of Common Stock
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Sarepta Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock

NEXT ARTICLE

More From BioPortfolio on "Sarepta Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock"

Quick Search
Advertisement